Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 28, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Land & Improvements (2011 - 2024)

Updated

Sinovac Biotech (SVA) recorded Land & Improvements of $10.88 million in Q1 2013, down 0.3% from the prior quarter.

Analysis

Sinovac Biotech (SVA) Land & Improvements (2011 - 2024) Analysis & Trends

At the end of FY2012, Sinovac Biotech reported Land & Improvements of $10.91 million, down 100.0% from FY2011.

  • Across earlier years, Land & Improvements came in at $11.64 trillion in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Sinovac Biotech 464.94 Mn -24.98 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 6.23 Mn
Dec 31, 2023 7.02 Mn
Dec 31, 2022 7.27 Mn
Dec 31, 2021 7.23 Mn
Mar 31, 2013 10.88 Mn
Dec 31, 2012 10.91 Mn
Dec 31, 2011 11,639.71 Bn
API Access

Sinovac Biotech Land & Improvements API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=land-and-improvements&ticker=SVA&period=max&api_key=YOUR_API_KEY